Actinium Pharmaceuticals reported $1000 in Interest Expense on Debt for its fiscal quarter ending in December of 2024.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Actinium Pharmaceuticals USD 1000 0 Dec/2024
Amgen USD 95.64B 94.98B Jun/2026
Bioline Rx USD 280K 80K Dec/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025
Pfizer USD 667M 4M Jun/2026